Surgery Partners, Inc. (SGRY) Guidance & Earnings Results

On 2026-08-10 Surgery Partners, Inc. reaffirmed guidance: "FY2026 revenue $3.35-3.45B; Adjusted EBITDA at least…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SGRYSurgery Partners, Inc.Follow SGRY — free

Medical Care Facilities · Healthcare

—

Price chart with a free account

Market cap: 2.1B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 10 Nov, in 17 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
10 Aug 26	Reaffirmed	FY2026 revenue $3.35-3.45B; Adjusted EBITDA at least $530M · full year
5 May 26	Reaffirmed	Revenue $3.35B-$3.45B; Adjusted EBITDA at least $530M · full year
2 Mar 26	Reaffirmed	Adjusted EBITDA at least $530M, revenue $3.35-3.45B · full year
10 Nov 25	Lowered	FY2025 revenue $3.275B-$3.30B, Adjusted EBITDA $535M-$540M · full year
5 Aug 25	Reaffirmed	FY2025 revenue $3.30-3.45B; FY2025 Adj EBITDA $555-565M · full year

Surgery Partners, Inc. — questions

What guidance did Surgery Partners, Inc. give?: On 2026-08-10: "FY2026 revenue $3.35-3.45B; Adjusted EBITDA at least $530M"
When does Surgery Partners, Inc. report earnings?: Surgery Partners, Inc.'s next earnings report is expected on 2026-11-10.

Every figure on this page comes from Surgery Partners, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.